Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WEEKLY MARKET DIGEST: POTENTIAL VIRUS MUTATION, CHINA HONG KONG POWER GRAB CHALLENGES TRUMP – STOCK MARKET OBLIVIOUS $DIA $GLD

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. MOMO BUYS THE TINY DIP ON CHINA CONCERNS, MARIJAUANA CORONAVIRUS SPECULATION May 22, 2020 To gain an edge, this is what you need to know today.

Read More »

790% GAIN ON DATA BASE SOFTWARE STOCK MONGODB, TARGET RAISED, BUYOUT CANDIDATE $MDB

This post was just published on ZYX Buy Change Alert.   MongoDB (MDB) is a data base software stock.  It is long from $24.  It is trading at $212 as of this writing.  This represents 790% gain. MDB remains a buyout candidate. To date, 155 of The Arora Report portfolio companies have been bought out producing a fortune for long time subscribers. Zones This is a very long term position. The target zone is being raised to the zone of $340 to $360. For those following the Good Way, the Buy Now rating is ‘NO’. For those following the Best Way, normally

Read More »

OVERSTOCK.COM 170% GAIN – TAKE PARTIAL PROFITS $OSTK

This post was just published on ZYX Buy Change Alert.   Overstock.com (OSTK) was bought at $6.61 as part of the January Effect trades.  Our call was to hold on to this position for the medium term.  The stock is trading at $18.04 as of this writing.  Depending upon the account size held, consider taking partial profits on one-third of the position in the zone of $17.38 to $19.88. Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007.  Please click here and scroll down to see the table of all trades.  These trades have been scrutinized in

Read More »

STOCK MARKET INVESTORS PAY ATTENTION TO SHIFT OF BILLIONS OF DOLLARS AWAY FROM POPULAR STOCKS $AMZN $CSCO $DIA $DJIA $FB $MRNA $MSFT $PTON $TDOC $WMT $WORK $ZM

Money is beginning to shift away from stocks that did well while the economy shut down to fight coronavirus. The shifts have picked up since Moderna announced impressive data from a Phase 1 trial for a vaccine against coronavirus. Now investors should look ahead to the post-vaccine world: Sell stocks that are hot today but will experience deteriorating earnings momentum after a vaccine comes out and buy quality stocks with good balance sheets that will experience positive earnings momentum in that new era. This chart compares the Dow Jones Industrial Average ETF DIA to seven stocks that I am using to illustrate shifts in

Read More »

VACCINE SUCCESS MAY UNLEASH THE SECOND LEG OF THE FORCE TO PROPEL THE STOCK MARKET TO NEW HIGHS $JNJ $PFE $MRNA $NVAX $INO $SRNE $DIA

Many investors not familiar with the mechanics of short squeezes are confused by the strength of the stock market rally that began after the S&P 500 hit a coronavirus low on March 23. Short-squeeze-related actions were the force that unleashed the strong rally. As the market continues to rally, the odds that the stock market will set a new record within the next two months are rising. I see it as 55% now, up from just 30% on May 13. As impressive as that rapid shift is, I will wait until the odds reach 70% to my call. What will

Read More »

CORONAVIRUS: SORRENTO THERAPEUTICS UP TO 139% GAIN AT THE HIGH IN TWO TRADING DAYS $SRNE

This post was just published on ZYX Buy Change Alert. Sorrento Therapeutics (SRNE) was purchased at $4.43 on Friday. It traded as high as $10.60 in the pre-market today.  The stock has backed off to $9.02 as of this writing. All subscribers should have taken partial profit or profits on the entire position based on personal preference.  There is a controversy about the treatment from Sorrento Therapeutics.  Some claim that it is a total fake while others have very high hopes.  For this reason, those deciding to hold on to a partial quantity may consider raising the stop  to the zone of

Read More »

WEEKLY MARKET DIGEST: PAY ATTENTION: FED CHAIR SAID SIGNIFICANT DOWNSIDE RISKS AHEAD $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. POOR RETAIL SALES, WILL TRUMP BOW TO CHINA TO SAVE APPLE, QUALCOMM, CISCO AND BOEING? May 15, 2020 To gain an edge, this is what you

Read More »

WILL TRUMP BOW TO CHINA TO SAVE APPLE, QUALCOMM, CISCO AND BOEING? $AAPL $AMZN $BA $CSCO $DIA $DJIA $FB $GOOG $MSFT $QCOM $SPX

Amid a debate about stock market investors underestimating the risks from the coronavirus-led shutdown of the global economy, China risk is reemerging. How the U.S. responds may determine the direction of the stock market. The U.S. has long contended that Chinese telecommunications-equipment maker Huawei Technologies is a risk to national security. It has been contended that the Chinese can spy on the U.S. and other countries through back doors built into Huawei technology. There is a report that the U.S. is amending an export rule to block the sale of certain semiconductors to Huawei. This is in addition to prior restrictions on

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content